- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Ankylosing spondylitis patients are at higher risk for Obstructive Sleep Apnea
Taiwan: Patients with newly diagnosed ankylosing spondylitis (AS) are at a 2.8-fold higher risk of developing obstructive sleep apnea (OSA) than the general population, according to a recent study published in the journal Frontiers in Medicine. The risk was especially high within 2 years after newly diagnosed AS and in the people aged 40–59 years.
Obstructive sleep apnea as a potentially serious sleep disorder with a damaging impact on the quality of life of the patient. It is characterized by repeated cessation of breathing during sleep. A noticeable sign of OSA is snoring.
Ankylosing spondylitis is a chronic inflammatory disease that primarily affects the spine, although other joints can become involved. It can lead to severe, chronic pain and discomfort. The prevalence of OSA in AS patients is higher than that reported in the general population, but it is not easy to identify OSA in AS patients if no detailed testing of polysomnography.
Chien-Han Tsao, Department of Otolaryngology, Chung Shan Medical University Hospital, Taichung, Taiwan, and colleagues investigated the risk of obstructive sleep apnea(OSA) among ankylosing spondylitis (AS) patients based on administrative healthcare databases.
For the purpose, the researchers conducted a nationwide cohort study by using the Taiwan National Health Insurance Research Database with 1997–2013 claim records. The AS cohort included 2,210 patients who were newly diagnosed between 2003 and 2013, 8840 healthy controls. Randomly selected non-AS controls were matched at a 1:4 ratio.
The endpoint was set as OSA occurrence or the end of 2013.
Key findings of the study include:
- The adjusted HR (aHR) of OSA in the AS group was 2.826 compared to the control group.
- On landmark analysis, aHR was 7.919 for the AS group 0–24 months from the index date and decreased to 1.816 at ≥ 24 months from the index date.
- The increased risks of OSA in the AS group compared to the control group were found for both males and females (aHRs were 4.533 and 2.672).
- On age-stratified analysis, a significant risk only for the 40–59 age group with aHR of 3.913.
"Further studies are recommended to clarify the underlying biological mechanisms of these associations. It is important to evaluate sleep quality and quantity for patients with AS to detect the occurrence of OSA and to reduce further complications," concluded the authors.
The study, "Ankylosing Spondylitis Is Associated With Risk of New-Onset Obstructive Sleep Apnea: A Nationwide Population-Based Cohort Study," is published in the journal Frontiers in Medicine.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751